TrialCirculation. Arrhythmia and electrophysiology2025

2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial.

Zachary T Yoneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.